Gansu State Capital Investment Group to Acquire Traditional Chinese Medicine Company Fochi Pharmaceutical for Up to RMB 1.87 Billion

Pencil News, Hanxin News Joint Report, September 21, 2023 – Foci Pharmaceutical (002644.SZ) released the "Tender Offer Report," stating that Gansu State Investment will become the controlling shareholder of Foci Pharmaceutical by purchasing 100% equity of Foci Group, thereby triggering a mandatory tender offer obligation. The tender offer price is 9.55 yuan per share, with an acquisition volume of 195,943,324 shares, and the maximum total funding amount is 1,871,258,744.20 yuan. This acquisition is not intended to terminate the listing status of Foci Pharmaceutical. Due to the acquirer fulfilling the tender offer obligation, the equity distribution of Foci Pharmaceutical does not meet the listing requirements. Its stock and derivatives will remain suspended until the equity distribution meets the listing conditions again and an announcement is made for resumption of trading. If the equity distribution still does not meet the listing requirements after one month, the stock will face delisting risk warnings. If the equity distribution issue is not resolved within six months or if it regains listing eligibility but no application to revoke the delisting risk warning is submitted, the stock will be delisted. Investors should be aware of the risks. The acquirer has the right to propose relevant suggestions or motions to maintain the listing status. If the final decision is to delist, remaining shareholders can sell their shares to the acquirer at the tender offer price.

According to the data, Foci Pharmaceutical (002644.SZ) was listed on the main board of the Shenzhen Stock Exchange on December 22, 2011. Its main business is the research, development, manufacturing, and sales of traditional Chinese medicine. The listing sponsor institution is: Hualong Securities Co., Ltd., with sponsors Liu Shengyao and Guo Ximing; the IPO accounting firm is: Richen Hao Hua Certified Public Accountants Co., Ltd., with practicing accountants Zhang Yabing and Liu Zhiwen; the IPO law firm is: Gansu Jingtian Law Firm, with practicing lawyers Wu Xiaoqi and Wang Sen.

As of the closing on September 20, 2023, the company's stock price was 11.16 yuan per share. The current market capitalization is 5.699 billion yuan.

The company's equity structure is as follows:

The shareholder name is: Lanzhou Foci Pharmaceutical Industry Development Group Co., Ltd., the announcement date is: August 3, 2023, the number of shares held is: 314,713,676 shares, and the equity percentage is: 61.629%;

The shareholder name is: Lu Haijun, the announcement date is: August 3, 2023, the number of shares held is: 8,900,531 shares, and the equity percentage is: 1.743%;

The shareholder name is: Industrial and Commercial Bank of China Co., Ltd. - Zhongou Healthcare Health Mixed Securities Investment Fund, the announcement date is: August 3, 2023, the number of shares held is: 7,650,775 shares, and the equity ratio is: 1.498%;

The shareholder name is: Chen Shihui, the announcement date is: August 3, 2023, the number of shares held is: 6,191,300 shares, and the equity percentage is: 1.212%;

The shareholder name is: Hong Kong Central Clearing Limited, the announcement date is: August 3, 2023, the number of shares held is: 5,874,245 shares, and the equity ratio is: 1.150%;

The shareholder name is: Kuwait Government Investment Bureau, the announcement date is: August 3, 2023, the number of shares held is: 3,571,120 shares, and the equity percentage is: 0.699%;

The shareholder name is: Zheng Muping, the announcement date is: August 3, 2023, the number of shares held is: 3,100,400 shares, and the equity percentage is: 0.607%;

The shareholder name is: Pengyun Xu, the announcement date is: August 3, 2023, the number of shares held is: 2,475,900 shares, and the equity percentage is: 0.485%;

The shareholder name is: Gao Jianmin, the announcement date is: August 3, 2023, the number of shares held is: 2,400,000 shares, and the equity percentage is: 0.470%;

The shareholder name is: Suqin Zuo, the announcement date is: August 3, 2023, the number of shares held is: 1,811,539 shares, and the equity percentage is: 0.355%;

Source of the announcement: http://static.cninfo.com.cn/finalpage/2023-09-21/1217905865.PDF

Disclaimer: This article was written by a robot, jointly incubated by Pencil Dao and Hanxin Society. Industrial and commercial data provided by Qichacha, other data provided by HanGuang Suwen. The content and data in this article are for reference only, do not constitute investment advice, please verify before use.